DXR Market Analysis
News & Sentiment
50 articles · sorted by datePage 1 of 3 · 50 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio6.40Forward 64.52
EPS (TTM)$1.64329.3% YoY
Profit margin34359.0%HEALTHCARE
Market cap$61.3MMicro cap
Valuation
- Forward P/E
- 64.52
- PEG ratio
- 0.00
- P/B
- 1.34
- P/S (TTM)
- 2296.99
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 22.5%
- Operating margin
- -9661.0%
- Revenue growth YoY
- -82.6%
- Dividend yield
- —
- Beta
- 0.26
Last earnings
Aug 29, 2025 · Estimate $0.00 · Reported $-0.07
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Daxor Corporation
Company profileDaxor Corporation, a medical device company, provides cryobank and biotechnology services in the United States. The company is headquartered in New York, New York.
Classification
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 109 MECO LANE, OAK RIDGE, TN
- Fiscal year end
- December
- Latest quarter
- Dec 31, 2025
Market cap$61.3M
Shares outstanding$5.8M
52W high$14.76
52W low$8.56
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent